Treatment of Tinea Corporis
Introduction to Treatment
- The American Academy of Dermatology recommends topical antifungal therapy as the first-line treatment for localized tinea corporis, with allylamine agents (terbinafine or naftifine) applied once daily for 1-2 weeks being preferred over azoles due to shorter treatment duration 1, 2
Topical Treatment
- Topical therapy alone is appropriate for localized, limited skin involvement in immunocompetent patients without treatment failure 1, 2
- Allylamine antifungals, such as terbinafine 1% cream applied once daily for 1-2 weeks, are preferred due to their shorter treatment duration compared to azoles 2
Oral Treatment
- Oral antifungal therapy is indicated when the infection is extensive or resistant to topical treatment, or in immunocompromised patients 1, 2
- Terbinafine is the first-line oral agent, with a dosage of 250 mg daily for 1-2 weeks, and achieves an 87.1% mycological cure rate at 6 weeks follow-up 1, 2
- Itraconazole is an alternative oral agent, with a dosage of 100 mg daily for 15 days, and achieves an 87% mycological cure rate 1, 2
Diagnostic Considerations
- The American Academy of Dermatology recommends confirming diagnosis before treatment by performing potassium hydroxide (KOH) preparation or fungal culture to identify the causative organism 1, 2
Treatment Monitoring and Endpoints
- Mycological cure, not just clinical response, is the definitive treatment endpoint, and follow-up with repeat mycology sampling until clearance is documented is necessary 1, 2
Prevention of Recurrence
- Essential preventive measures include screening and treating all family members, as over 50% of household contacts may be affected with anthropophilic species like T. tonsurans 1, 2
- Cleaning all fomites (combs, brushes, towels) with disinfectant or 2% sodium hypochlorite solution is also recommended 1, 2
Common Pitfalls to Avoid
- Griseofulvin should not be used as first-line therapy due to its longer treatment duration and lower efficacy compared to terbinafine 1